News Image

Will ABBVIE INC breakout?

By Mill Chart

Last update: Mar 29, 2023

A possible breakout setup was detected on ABBVIE INC (NYSE:ABBV) by our stockscreener. A breakout pattern is formed when a stock consolidates after a strong rise up. We note that this pattern is detected purely based on technical analysis and whether the breakout actually materializes remains to be seen. It could be interesting to keep an eye on NYSE:ABBV.

ABBV Daily chart on 2023-03-29

Technical analysis of NYSE:ABBV

ChartMill assigns a proprietary Technical Rating to each stock. The score is computed daily by evaluating various technical indicators and properties. The score ranges from 0 to 10.

We assign a technical rating of 7 out of 10 to ABBV. Although ABBV is only a medium performer in the overall market, the technical picture looks good in both the medium and short term time frames.

  • The long and short term trends are both positive. This is looking good!
  • ABBV is one of the better performing stocks in the Biotechnology industry, it outperforms 75% of 638 stocks in the same industry.
  • In the last month ABBV has a been trading in the 146.57 - 159.14 range, which is quite wide. It is currently trading near the high of this range.
  • When compared to the yearly performance of all other stocks, ABBV outperforms 66% of them, which is more or less in line with the market.
  • ABBV is currently trading in the middle of its 52 week range. This is in line with the S&P500 Index, which is also trading in the middle of its range.

How does the Setup look for NYSE:ABBV

Next to the Technical Rating, the Setup Rating of a stock determines to which extend the stock is consolidating. This score also ranges from 0 to 10 and is updated daily. The setup score evaluates various short term technical indicators. For NYSE:ABBV this score is currently 8:

Besides having an excellent technical rating, ABBV also presents a decent setup pattern. We see reduced volatility while prices have been consolidating in the most recent period. There is very little resistance above the current price. There is a support zone below the current price at 156.48, a Stop Loss order could be placed below this zone.

How to trade NYSE:ABBV?

For a potential trade one would typically wait until the stock breaks out of the consolidation zone to enter the stock and it could be sold again for a loss when it would fall back below the zone.

Of course, there are many ways to trade or not trade NYSE:ABBV and this article should in no way be interpreted as trading advice. The article is purely based on an automated technical analysis and just points out the technical observations. Always make your own analysis and trade at your own responsibility.

Every day, new breakout setups can be found on ChartMill in our Breakout analyzer.

Back

ABBVIE INC

NYSE:ABBV (4/18/2024, 7:04:00 PM)

After market: 164.99 +0.33 (+0.2%)

164.66

+0.41 (+0.25%)

ABBV News

News Image20 hours ago - AbbViePhase 3 SELECT-GCA Study of Upadacitinib (RINVOQ®) Showed Positive Results in Patients With Giant Cell Arteritis

− Results from the Phase 3 SELECT-GCA study showed 46 percent of patients with giant cell arteritis (GCA) who were treated with upadacitinib (RINVOQ®; 15 mg)...

News Image3 days ago - InvestorPlaceSteady Income, Steady Growth: 7 Blue-Chip Dividend Stocks to Buy Now

With an already tense situation becoming even more troubling, now’s the time to consider blue-chip dividend stocks to buy.

News Image4 days ago - Investor's Business DailyNeumora Stock Hits 2024 Low As Side Effects In Rabbits Torpedo Schizophrenia Drug

The company was testing a potential treatment for schizophrenia in rabbits, but found a notable side effect.

News Image4 days ago - Market News VideoSee Which Of The Latest 13F Filers Holds AbbVie
News Image5 days ago - The Motley FoolIs AbbVie a Millionaire Maker?

Everything is going according to plan, and more growth is on the way.

News Image7 days ago - Glancy Prongay & Murray LLPGlancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of AbbVie Inc. (ABBV) on Behalf of Investors
News Image7 days ago - Law Offices of Howard G. SmithINVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of AbbVie Inc. (ABBV) on Behalf of Investors
News Image7 days ago - Market News VideoNotable Friday Option Activity: TGT, ABBV, DIS
News Image7 days ago - AbbVieAbbVie Announces Late-Breaking Data at AAN Supporting Long-Term Safety and Efficacy of Atogepant (QULIPTA®) for Preventive Treatment of Migraine

- Interim analysis of an ongoing 156-week extension study supports long-term safety, tolerability and efficacy of atogepant 60 mg to prevent chronic and...

News Image8 days ago - InvestorPlaceWall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for April 2024

In a stock picker’s market, here are three biotech stocks analysts believe have a chance to outperform the market in 2024.

News Image15 days ago - ChartmillThursday's session: top gainers and losers in the S&P500 index

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Thursday.

News Image15 days ago - ChartmillWhich S&P500 stocks are moving on Thursday?

Stay informed about the performance of the S&P500 index in the middle of the day on Thursday. Uncover the top gainers and losers in today's session for valuable insights.

ABBV Links
Follow us for more